Evidence map›Paper›PMID 39003450›Full record

ArticleJournal of neuroengineering and rehabilitation2024

Inter-joint coordination with and without dopaminergic medication in Parkinson's disease: a case-control study.

Karolina Saegner, Robbin Romijnders, Clint Hansen, Jana Holder, Elke Warmerdam, Walter Maetzler

Abstract read
In one paragraph

Article in Journal of neuroengineering and rehabilitation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Karolina SaegnerDepartment of Neurology, University Hospital Schleswig-Holstein, Campus Kiel and Kiel University, Arnold-Heller Str. 3, Kiel, 24105, Germany. karolina.saegner@uksh.de.
Robbin RomijndersDepartment of Neurology, University Hospital Schleswig-Holstein, Campus Kiel and Kiel University, Arnold-Heller Str. 3, Kiel, 24105, Germany.
Clint HansenDepartment of Neurology, University Hospital Schleswig-Holstein, Campus Kiel and Kiel University, Arnold-Heller Str. 3, Kiel, 24105, Germany.
Jana HolderDepartment of Sport and Exercise Science, University of Salzburg, Salzburg, Austria.
Elke WarmerdamDepartment of Neurology, University Hospital Schleswig-Holstein, Campus Kiel and Kiel University, Arnold-Heller Str. 3, Kiel, 24105, Germany.
Walter MaetzlerDepartment of Neurology, University Hospital Schleswig-Holstein, Campus Kiel and Kiel University, Arnold-Heller Str. 3, Kiel, 24105, Germany. w.maetzler@neurologie.uni-kiel.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHow the joints exactly move and interact and how this reflects PD-related gait abnormalities and the response to dopaminergic treatment is poorly understood. A detailed understanding of these kinematics can inform clinical management and treatment decisions. The aim of the study was to investigate the influence of different gait speeds and medication on/off conditions on inter-joint coordination, as well as kinematic differences throughout the whole gait cycle in well characterized pwPD.

methods29 controls and 29 PD patients during medication on, 8 of them also during medication off walked a straight walking path in slow, preferred and fast walking speeds. Gait data was collected using optical motion capture system. Kinematics of the hip and knee and coordinated hip-knee kinematics were evaluated using Statistical Parametric Mapping (SPM) and cyclograms (angle-angle plots). Values derived from cyclograms were compared using repeated-measures ANOVA for within group, and ttest for between group comparisons.

resultsPD gait differed from controls mainly by lower knee range of motion (ROM). Adaptation to gait speed in PD was mainly achieved by increasing hip ROM. Regularity of gait was worse in PD but only during preferred speed. The ratios of different speed cyclograms were smaller in the PD groups. SPM analyses revealed that PD participants had smaller hip and knee angles during the swing phase, and PD participants reached peak hip flexion later than controls. Withdrawal of medication showed an exacerbation of only a few parameters.

conclusionsOur findings demonstrate the potential of granular kinematic analyses, including > 1 joint, for disease and treatment monitoring in PD. Our approach can be extended to further mobility-limiting conditions and other joint combinations.

trial registrationThe study is registered in the German Clinical Trials Register (DRKS00022998, registered on 04 Sep 2020).

Indexed as

Dopamine AgentsParkinson DiseaseRange of Motion, ArticularAgedBiomechanical PhenomenaCase-Control StudiesFemaleGaitGait Disorders, NeurologicHip JointHumansJointsKnee JointMaleMiddle AgedDopamine AgentsCyclogramGaitKinematicsMotion captureNeurogeriatricsStatistical parametric mapping

Identifiers

PMID39003450
PMCPMC11245779

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.